Pace Analytical Life Sciences, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 160 N Pharma Dr, Morrisville, North Carolina (NC) 27560-9570, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 3032846997 · DUNS 014167995
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2026-07-10
Drugs this plant is listed as making
8 distinct drugs across 26 products name this site in their FDA label.
- Dextroamphetamine SulfateAmneal Pharmaceuticals of New York LLC
- guanfacineTakeda Pharmaceuticals America, Inc.
- lemborexantEisai Inc.
- perampanelEisai Inc.
- ponatinib hydrochlorideTakeda Pharmaceuticals America, Inc.
- rufinamideEisai Inc.
- TobramycinGenericus, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.